Research

Topics Publications In progress publications Communications

Packages

AnaQol Project PRO-online R Packages Online R-package

Life of the unit

Projects Collaborations PhD thesis Traineeships Traineeships propositions Seminars

Next seminars

27 juin 2019 Raphaël Cinotti Présentation des titres & travaux

Last publications

01 mai 2019 Karsenti D, Tharsis G, Zeitoun J, Denis P, Perrot B, Coelho J, Bellaiche G, Charbit L, Hakoune J, Doumet S, Sion-Rohart E, Cavicchi M, Zago J (2019) Comparison of 20-gauge Procore® and 22-gauge Acquire® needles for EUS-FNB of solid pancreatic masses: an observational study. Scandinavian Journal of Gastroenterology, 8: 1-7.

09 avril 2019 Rouquette A, Hardouin JB, Vanhaesebrouck A, Sébille V, Coste J (2019) Differential Item Functioning (DIF) in composite health measurement scale: recommendations for characterizing DIF with meaningful consequences within the Rasch model framework.. PLOS One, 14(4): e0215073.

15 mars 2019 Quénéhervé L, David G, Bourreille , Hardouin JB, Rahmi G, Neunlist M, Brégeon J, Coron E (2019) Quantitative assessment of mucosal architecture using computer-based analysis of confocal laser endomicroscopy in inflammatory bowel diseases. Gastrointestinal Endoscopy, 89(3): 626-636.

07 mars 2019 Prudhomme T, Dajean-Trutaud S, Rousselet M, Feuillet F, Carpentier-Cheraud M, Bonnot O, Hyon I, Grall-Bronnec M, Lopez-Cazaux S, Victorri-Vigneau C (2019) The MEOPAeDent trial protocol—an observational study of the Equimolar Mixture of Oxygen and Nitrous Oxide (EMONO) effects in paediatric dentistry. BMC Oral Health, 19: 42.

01 mars 2019 Leducq S, Giraudeau B, Tavernier E, Maruani A (2019) Topical use of mammalian target of rapamycin inhibitors in dermatology: A systematic review with meta-analysis. J Am Acad Dermatol, 80(3): 735-42.

Updated

24 mai 2019

Véronique Sébille

Situation

Poste : PU-PH Biostatistique - Directrice de l'unité SPHERE
Institution : Université de Nantes - UFR de Pharmacie
Email : veronique.sebille@univ-nantes.fr

Publications scientifiques

Articles dans une revue internationale

1. Rouquette A, Hardouin JB, Vanhaesebrouck A, Sébille V, Coste J (2019) Differential Item Functioning (DIF) in composite health measurement scale: recommendations for characterizing DIF with meaningful consequences within the Rasch model framework.. PLOS One, 14(4): e0215073.
2. Le Turnier P, Navas D, Garot D, Guimard T, Bernard L, Tattevin P, Vandamme Y, Hoff J, Chiffoleau A, Dary M, Leclair-Visonneau L, Gregoire M, Pere M, Boutoille D, Sébille V, Dailly E, Asseray N, High-Dose Ceftriaxone CNS Infections Study Group (2019) Tolerability of high-dose ceftriaxone in CNS infections: a prospective multicentre cohort study. J Antimicrob Chemother: doi: 10.1093/jac/dky553. [Epub ahead of print].
3. Foucher Y, Lorent M, Tessier P, Supiot S, Sébille V, Dantan E (2018) A mini-review of quality of life as an outcome in prostate cancer trials: patient-centered approaches are needed to propose appropriate treatments on behalf of patients. Health Qual Life Outcomes, 16(1): 40.
4. Sauvaget A, Bulteau S, Guilleux A, Leboucher J, Pichot A, Valrivière P, Vanelle J, Sébille V, Grall-Bronnec M (2018) Both active and sham low-frequency rTMS single sessions over the right DLPFC decrease cue-induced cravings among pathological gamblers seeking treatment: A randomized, double-blind, sham-controlled crossover trial. J Behav Addict, 7(1): 126-136.
5. Asehnoune K, Lasocki S, Seguin P, Geeraerts T, Perrigault P, Dahyot-Fizelier C, Paugam-Burtz C, Cook F, Demeure Dit Latte D, Cinotti R, Mahé PJ, Fortuit C, Pirracchio R, Feuillet F, Sébille V, Roquilly A (2017) Association between continuous hyperosmolar therapy and survival in patients with traumatic brain injury - a multicentre prospective cohort study and systematic review.. Critical Care, 21(1): 328.
6. Hamel JF, Sébille V, Le Neel T, Kubis G, Boyer F, Hardouin JB (2017) What are the appropriate methods for analyzing patients reported outcomes in randomized trials when data are missing?. Statistical Methods in Medical Research, 26(6): 2897-2908.
7. Salmon M, Blanchin M, Rotonda C, Guillemin F, Sébille V (2017) Identifying patterns of adaptation in breast cancer patients with cancer-related fatigue using response shift analyses at subgroup level. Cancer Medicine, 6(11): 2562-2575.
8. Asehnoune K, Seguin P, Lasocki S, Roquilly A, Delater A, Gros A, Denou F, Mahé PJ, Nesseler N, Demeure Dit Latte D, Launey Y, Lakhal K, Rozec B, Mallédant Y, Sébille V, Jaber S, Le Thuaut A, Feuillet F, Cinotti R (2017) Extubation Success Prediction in a Multicentric Cohort of Patients with Severe Brain Injury. Anesthesiology, 127(2): 338-346.
9. Lamirault G, de Bock E, Sébille V, Delasalle B, Roncalli J, Susen S, Piot C, Trochu JN, Teiger E, Neuder Y, Le Tourneau T, Manrique A, Hardouin JB, Lemarchand P (2017) Sustained quality of life improvement after intracoronary injection of autologous bone marrow cells in the setting of acute myocardial infarction: results from the BONAMI trial. Quality of Life Research, 26(1): 121-125.
10. Tessier P, Blanchin M, Sébille V (2017) Does the relationship between health-related quality of life and subjective well-being change over time? An exploratory study among breast cancer patients. Social Science & Medicine, 174: 96-103.
11. de Bock E, Hardouin JB, Blanchin M, Le Neel T, Kubis G, Dantan E, Bonnaud-Antignac A, Sébille V (2016) Rasch-family models are more valuable than score-based approaches for analysing longitudinal PRO with intermittent missing data. Statistical Methods in Medical Research , 25(5): 2067–2087.
12. Vourc’h M, Feuillet F, Mahé PJ, Sébille V, Asehnoune K (2016) Baclofen to prevent agitation in alcoholaddicted patients in the ICU: study protocol for a randomised controlled trial. Trials, 17(1): 415.
13. Bourdon M, Blanchin M, Tessier P, Campone M, Quéreux G, Dravet F, Sébille V, Bonnaud-Antignac A (2016) Changes in quality of life after a diagnosis of cancer: A two-year study comparing breast cancer and melanoma patients. Quality of Life Research, 25(8): 1969-1979.
14. Blanchin M, Hardouin JB, Bonnaud-Antignac A, Sébille V (2016) Analysis of longitudinal patient reported outcomes data with Classical Test Theory and Rasch-based methods: an application on health-related quality of life in breast cancer patients. Statistica Applicata – Italian Journal of Applied Statistics, 27(1): 41-56.
15. Hamel JF, Sébille V, Challet G, Hardouin JB (2016) Partial Credit Model: estimations and tests of fit with pcmodel. Stata Journal, 16(2): 464-481.
16. Victorri-Vigneau C, Hardouin JB, Rousselet M, Gérardin M, Guerlais M, Guillou-Landreat M, Grall-Bronnec M, Sébille V, Jolliet P, and the French Addictovigilance network (2016) Multicentre study for the validation of the French addictovigilance network reports assessment tool. British Journal of Clinical Pharmacology, 82: 1030-1039.
17. Blanchin M, Sébille V, Guilleux A, Hardouin JB (2016) The Guttman errors as a tool for response shift detection at subgroup and item levels. Quality of Life Research, 25(6): 1385-1393.
18. Roquilly A, Feuillet F, Seguin P, Lasocki S, Cinotti R, Launey Y, Thioliere L, Le Floch R, Mahé PJ, Nesseler N, Cazaubiel T, Rozec B, Lepelletier D, Sébille V, Mallédant Y, Asehnoune K (2016) Empiric antimicrobial therapy for ventilator-associated pneumonia after brain injury. Eur Respir J, 47(4): 1219-28.
19. Sébille V, Hardouin JB, Giral M, Bonnaud-Antignac A, Tessier P, Papuchon E, Jobert A, Faurel-Paul E, Gentile S, Cassuto R, Morelon E, Rostaing L, Glotz D, Sberro-Soussan R, Foucher Y, Meurette A (2016) Prospective, multicenter, controlled study of quality of life, psychological adjustment process and medical outcomes of patients receiving a preemptive kidney transplant compared to a similar population of recipients after dialysis. BMC Nephrol, 17(1): 11.
20. Duclay E, Hardouin JB, Sébille V, Anthoine E, Moret L (2015) Exploring the Impact of staff absenteism on patient satisfaction using routinely indicators in a university hospital. Journal of Nursing Management, 23(7): 833-841.
21. Feddag ML, Sébille V, Blanchin M, Hardouin JB (2015) Estimation of parameters of the Rasch model and comparison of groups in presence of locally dependent items. Journal of Applied Measurement, 16(3): 268-77.
22. Vanier A, Sébille V, Blanchin M, Guilleux A, Hardouin JB (2015) Overall performance of Oort's procedure for response shift detection at item-level: a pilot simulation study. Quality of life research, 24(8): 1799-807.
23. Hardouin JB, Blanchin M, Feddag ML, Le Neel T, Perrot B, Sébille V (2015) Power and sample size determination for group comparison on Patient Reported Outcomes using polytomous Rasch models. Statistics in Medicine, 34(16): 2444-55.
24. Vanier A, Leplège A, Hardouin JB, Sébille V, Falissard B (2015) Semantic primes theory may be helpful in designing questionnaires such as to prevent response shift. Journal of Clinical Epidemiology, 68(6): 646-654.
25. Feuillet F, Bellanger L, Hardouin JB, Victorri-Vigneau C, Sébille V (2015) On comparison of clustering methods for pharmacoepidemiological data. Journal of Biopharmaceutical Statistics, 25(4): 843-856.
26. Blanchin M, Guilleux A, Perrot B, Bonnaud-Antignac A, Hardouin JB, Sébille V (2015) Power and sample size determination for the group comparison of patient-reported outcomes using the Rasch model: impact of a misspecification of the parameters. BMC Medical Research Methodology, 15: 21.
27. Guilleux A, Blanchin M, Vanier A, Guillemin F, Falissard B, Schwartz C, Hardouin JB, Sébille V (2015) RespOnse Shift ALgorithm in Item response theory (ROSALI) for response shift detection with missing data in longitudinal patient-reported outcome studies. Quality of life research, 24(3): 553-564.
28. de Bock E, Hardouin JB, Blanchin M, Le Neel T, Kubis G, Sébille V (2015) Assessment of score and Rasch-based methods for group comparison of longitudinal Patient-Reported Outcomes with intermittent missing data (informative and non-informative). Quality of Life Research, 24(1): 19-29.
29. Anthoine E, Moret L, Regnault A, Sébille V, Hardouin JB (2014) Sample size used to validate a scale: a review of publications on newly-developed patient reported outcomes measures. Health and Quality of Life Outcomes, 12: 176.
30. Feddag ML, Blanchin M, Hardouin JB, Sébille V (2014) Power analysis on the time effect for the longitudinal Rasch model. Journal of Applied Measurement, 15(3): 292-301.
31. Sébille V, Blanchin M, Guillemin F, Falissard B, Hardouin JB (2014) A simple ratio-based approach for power and sample size determination for Rasch analysis. BMC Medical Research Methodology, 14(1): 87.
32. Guillou-Landreat M, Sébille V, Victorri-Vigneau C, Foucher Y, Vénisse JL, Jolliet P (2014) Buprenorphine prescription compliance: an original observational and longitudinal study. Journal of Psychoactive Drugs, 46(2): 162-7.
33. Rouquette A, Blanchin M, Sébille V, Guillemin F, Côté SM, Falissard B, Hardouin JB (2014) Determination of the Minimal Clinically Important Difference using Item Response Theory Models: an attempt to solve the issue of the association with baseline score. Journal of Clinical Epidemiology, 64(4): 433-440.
34. Roquilly A, Seguin P, Mimoz O, Feuillet F, Rosenczvei E, Chevalier F, Loutrel O, Mallédant Y, Sébille V, Asehnoune K (2014) Risk factors for prolonged duration of mechanical ventilation in acute traumatic tetraplegic patients-a retrospective cohort study. J Crit Care, 29(2): 313.e7-13.
35. Boyer L, Baumstarck K, Michel P, Boucekine M, Anota A, Bonnetain F, Coste J, Falissard B, Guilleux A, Hardouin JB, Loundou A, Mercier M, Mesbah M, Rouquette A, Sébille V, Verdam M, Ghattas B, Guillemin F, Auquier P (2014) Statistical challenges in quality of life and cancer: New avenues for future researches. Expert Review of Pharmacoeconomics & Outcomes Research, 14(1): 19-22.
36. Guilleux A, Blanchin M, Hardouin JB, Sébille V (2014) Power and sample size determination in the Rasch model: Evaluation of the robustness of a numerical method to non-normality of the latent trait. Plos One, 9(1): e0083652.
37. Lucas JP, Bellanger L, Le Strat Y, Le Tertre A, Glorennec P, Le Bot B, Etchevers A, Mandin C, Sébille V (2014) Source Contribution of Lead in Residential Floor Dust and Within-Home Variability of Dust Lead Loading. Science of the Total Environment, 70(127): 768-779.
38. Victorri-Vigneau C, Collin C, Messina-Gourlot M, Raffournier C, Mallaret M, Besse J, Courné MA, Richard N, Sébille V, Arnaud P, participants of expert group of the study (2014) Designing a tool allowing for a standardized assessment of resistance to drug diversion. Expert Opin Drug Deliv, 11(7): 995-1004.
39. Camus C, Sébille V, Legras A, Garo B, Renault A, Le Corre P, Donnio PY, Gacouin A, Perrotin D, Le Tulzo Y, Bellissant E (2014) Mupirocin/chlorexidine to prevent methicillin-resistant Staphylococcus aureus infections: post hoc analysis of a placebo-controlled, randomized trial using mupirocin/chlorhexidine and polymyxin/tobramycin for the prevention of acquired infections in intub. Infection, 42(3): 493-502.
40. Schwartz C, Sajobi T, Verdam M, Sébille V, Lix L, Guilleux A, Sprangers M (2014) Method variation in the impact of missing data on response shift detection. Quality of Life Research : .
41. Audrain M, Thomas C, Mirallie S, Bourgeois N, Sébille V, Rabetrano H, Durand-Zaleski I, Boisson R, Persyn M, Pierres C, Mahlaoui N, Fischer A (2014) Evaluation of the T-cell receptor excision circle assay performances for severe combined immunodeficiency neonatal screening on Guthrie cards in a French single centre study. Clinical Immunology, 150(2): 137-139.
42. Lucas JP, Sébille V, Le Tertre A, Le Strat Y, Bellanger L (2013) Multilevel modelling on survey data: impact of the 2-level weights used in the pseudolikelihood. Journal of Applied Statistics: published online.
43. Roquilly A, Cinotti R, Jaber S, Vourc’h M, Pengam F, Mahé PJ, Lakhal K, Demeure Dit Latte D, Rondeau N, Loutrel O, Paulus J, Rozec B, Blanloeil Y, Vibet MA, Sébille V, Feuillet F, Asehnoune K (2013) Implementation of an evidence-based extubation readiness bundle in 499 brain-injured patients - a before-after evaluation of a quality improvement project. American Journal of Respiratory and Critical Care Medicine, 188(8): 958-966.
44. Victorri-Vigneau C, Feuillet F, Wainstein L, Grall-Bronnec M, Pivette J, Chaslerie A, Sébille V, Jolliet P (2013) Pharmacoepidemiological characterisation of zolpidem and zopiclone usage. Eur J Clin Pharmacol, 69(11): 1965-1972.
45. Roquilly A, Perbet S, Simonneau F, Cinotti R, Sébille V, Volteau C, Gratas C, Minet-Quinard R, Loutrel O, Rozec B, Lejus C, Constantin JM, Asehnoune K (2013) Ammonia plasma concentration and prolonged infusion of remifentanil in patients with acute kidney injury. Minerva Anestesiol: .
46. Blanchin M, Hardouin JB, Guillemin F, Falissard B, Sébille V (2013) Power and sample size determination for the group comparison of patient-reported outcomes with Rasch family models. PLoS ONE, 8(2): e57279.
47. Le Bras M, Roquilly A, Deckert V, Langhi C, Feuillet F, Sébille V, Mahé PJ, Bach K, Masson D, Lagrost L, Costet P, Asehnoune K, Cariou B (2013) Plasma PCSK9 Is a Late Biomarker of Severity in Patients With Severe Trauma Injury. J Clin Endocrin Metab, 98(4): E732-736.
48. Bellanger L, Victorri-Vigneau C, Pivette J, Jolliet P, Sébille V (2013) Discrimination of psychotropic drugs over-consumers using a threshold exceedance based approach. Statistical Analysis and Data-Mining, 6(2): 91-101.
49. Bobin-Dubigeon C, Biron C, Volteau C, Piroth L, Biron A, Perré P, Leport C, Prazuck T, Sébille V, Raffi F, Bard J (2013) Short communication: Paraoxonase 1 (PON1) in French HIV-infected patients under antiretroviral therapy: relationship with the metabolic syndrome and inflammation. AIDS Research and Human Retroviruses, 29(12): 1571-1574.
50. Orsonneau J, Fraissinet F, Sébille V, Dudouet D, Bigot-Corbel E (2013) Suitability of POC lactate methods for fetal and perinatal lactate testing: considerations for accuracy, specificity and decision making criteria. Clinical Chemistry and Laboratory Medicine, 51(2): 397-404.
51. Grall-Bronnec M, Challet G, Sébille V, Gorwood P, Boutin C, Vénisse JL, Hardouin JB (2012) A French adaptation of the Gambling Related Cognitions Scale (GRCS): A useful tool for assessment of irrational thoughts among gamblers. Journal of Gambling Issues, 27: 1-21.
52. Hamel JF, Hardouin JB, Le Neel T, Kubis G, Roquelaure Y, Sébille V (2012) Study of different methods for comparing groups by analysis of subjective health measurements. PLoS One, 7(10): e44695.
53. Decaux O, Renault A, Sébille V, Moreau P, Attal M, Voillat L, Pegourie B, Tiab M, Facon T, Zerbib R, Grosbois B, Bellissant E, Intergroupe Francophone du Myélome (2012) Predictive factors of survival after thalidomide therapy in advanced multiple myeloma: long-term follow-up of a prospective multicenter nonrandomized phase II study in 120 patients. Clin Lymphoma Myeloma Leuk, 12(6): 418-22.
54. Bonnaud-Antignac A, Hardouin JB, Léger J, Dravet F, Sébille V (2012) Quality of life and coping of women treated for breast cancer and their caregivers. What are the interactions?. Journal of Clinical Psychology in Medical Settings, 19: 320-328.
55. Grall-Bronnec M, Wainstein L, Feuillet F, Challet G, Rocher B, Vénisse JL, Sébille V (2012) Clinical profiles as a function of level and type of impulsivity in a sample group of at-risk and pathological gamblers seeking treatment. J Gambl Stud, 28(2): 239-252.
56. Hardouin JB, Amri S, Feddag ML, Sébille V (2012) Towards Power And Sample Size Calculations For Item Response Theory Analysis For The Comparison Of Two Groups Of Patients. Statistics in Medicine, 31(11): 1277-1290.
57. Feddag ML, Hardouin JB, Sébille V (2012) Pairwise- and marginal-likelihood estimation for the mixed Rasch model with binary data . Journal of Statistical Computation and Simulation , 82(3): 419-430.
58. Lucas JP, Le Bot B, Glorennec P, Etchevers A, Bretin P, Douay F, Sébille V, Bellanger L, Mandin C (2012) Lead Contamination in French Children’s Homes and Environment. Environmental Research, 116: 58–65.
59. Asehnoune K, Mahé PJ, Seguin P, Jaber S, Jung B, Guitton C, Chatel-Josse N, Subileau A, Tellier AC, Masson F, Renard B, Mallédant Y, Lejus C, Volteau C, Sébille V, Roquilly A (2012) Etomidate increases susceptibility to pneumonia in trauma patients. Intensive Care Medicine, 38(10): 1673-1682.
60. Touzeau C, Gagne K, Sébille V, Herry P, Chevallier P, Folléa G, Devys A, Moreau P, Mothy M, Cesbron Gautier A (2012) . Investigation of the impact of HLA-DPB1 matching status in 10/10 HLA matched unrelated hematopoietic stem cell transplantation: results of a French single center study. Human Immunology , 73(7): 711-714.
61. Biron A, Bobin-Dubigeon C, Volteau C, Piroth L, Perré P, Leport C, Prazuck T, Jovelin T, Billard M, Sébille V, Bard J, Raffi F, Biron C (2012) Metabolic syndrome in French HIV-infected patients: prevalence and predictive factors after 3 years of antiretroviral therapy. AIDS Research and Human Retroviruses, 28(12): 1672-1678.
62. Grall-Bronnec M, Wainstein L, Augy J, Challet G, Feuillet F, Vénisse JL, Sébille V (2011) Attention deficit hyperactivity disorder among pathological and at-risk gamblers seeking treatments: a hidden disorder. Eur Addict Res, 17(5): 231-240.
63. Aboab J, Sébille V, Jourdain M, Mangalaboyi J, Gharbi M, Mansart A, Annane D (2011) Effects of esmolol on systemic and pulmonary hemodynamics and on oxygenation in pigs with hypodynamic endotoxin shock. Intensive Care Medicine, 37(8): 1344-1351.
64. Hardouin JB, Conroy R, Sébille V (2011) Imputation by the mean score should be avoided when validating a Patient Reported Outcomes questionnaire by a Rasch model in presence of informative missing data. BMC Medical Research Methodology, 11(105): 1-13.
65. Roquilly A, Mahé PJ, Seguin P, Floch H, Tellier AC, Merson L, Renard B, Mallédant Y, Flet L, Sébille V, Volteau C, Masson D, NGuyen JM, Lejus C, Asehnoune K (2011) Hydrocortisone therapy for patients with multiple trauma: the randomized controlled HYPOLYTE study. JAMA: 1201-1209.
66. Blanchin M, Hardouin JB, Le Neel T, Kubis G, Blanchard C, Mirallié E, Sébille V (2011) Comparison of CTT and IRT based-approach for the analysis of longitudinal Patient Reported Outcome . Statistics in Medicine, 30(8): 825-838.
67. Wainstein L, Victorri-Vigneau C, Sébille V, Hardouin JB, Feuillet F, Pivette J, Chaslerie A, Jolliet P (2011) Pharmacoepidemiological characterization of psychotropic drugs consumption using a latent class analysis. International Clinical Psychopharmacology, 26(1): 54-62.
68. Hardouin JB, Bonnaud-Antignac A, Sébille V (2011) Non parametric Item Response Theory using Stata. The Stata Journal, 11(1): 30-51.
69. Blanchin M, Hardouin JB, Le Neel T, Kubis G, Sébille V (2011) Analysis of longitudinal Patient-Reported Outcomes with informative and non-informative dropout: Comparison of CTT and Rasch-based methods. International Journal of Applied Mathematics & Statistics (IJAMAS), 24: SI-11A.
70. Guitton C, Gérard N, Sébille V, Villers D, Boutoleau-Bretonnière C, Quillard T, Charreau B (2011) Early rise in circulating endothelial protein C receptor correlates with poor outcome in severe sepsisechanisms in vascular endothelial cells. Intensive Care Medicine, 37(6): 950-956.
71. Tripodi D, Ferron C, Malard O, De Montreuil C, Planche L, Sébille V, Roedlich C, Quéméner S, Renaudin K, Longuenesse C, Verger C, Meflash K, Gratas C, Géraut C (2011) Relevance of both individual risk factors and occupational exposure in cancer survival studies: the example of intestinal type sinonasal adenocarcinoma. Laryngoscope, 121(9): 2011-2018.
72. Asehnoune K, Roquilly A, Sébille V (2011) Corti-TC trial group. Corticotherapy for traumatic brain-injured patients--the Corti-TC trial: study protocol for a randomized controlled trial. Trials, 12: 228.
73. Victorri-Vigneau C, Sébille V, Gérardin M, Simon D, Pivette J, Jolliet P (2011) Epidemiological characterization of drug overconsumption: the example of antidepressants. Journal of Addictive Disease, 30(4): 342-350.
74. Roquilly A, Mahé J, Latte D, Loutrel O, Champin P, Di Falco C, Courbe A, Buffenoir K, Hamel O, Lejus C, Sébille V, Asehnoune K (2011) Continuous controlled-infusion of hypertonic saline solution in traumatic brain-injured patients: a 9-year retrospective study. Critical Care , 15(5): R260.
75. Furby A, Beauvais K, Kolev I, Rivain JG, Sébille V (2010) Rural environment and risk factors of amyotrophic lateral sclerosis: a case-control study. Journal of Neurology, 257(5): 792-798.
76. Miqueu P, Degauque N, Guillet M, Giral M, Ruiz C, Pallier A, Braudeau C, Roussey-Kesler , Asthon-chess J, Dore J, Thervet E, Legendre C, Hernandez-Fuentez MP, Warrens A, Volk HD, Janssen U, Wood KJ, Lechler RI, Bertrand D, Sébille V (2010) Analysis of the peripheral T cell repertoire in kidney transplant patients. European Journal of Immunology, 40(11): 3280-3290.
77. Pottier P, Hardouin JB, Hodges BD, Pistorius MA, Connault J, Durant C, Clairand R, Sébille V, Barrier JH, Planchon B (2010) Exploring how students think: a new method combining think-aloud and concept mapping protocols. Medical Education, 44(9): 926-935.
78. Sébille V, Hardouin JB, Le Neel T, Kubis G, Boyer F, Guillemin F, Falissard B (2010) Methodological issues regarding power of Classical Test Theory (CTT) and Item Response Theory (IRT)-based approaches for the comparison of Patient-Reported Outcomes in two groups of patients - A simulation study. BMC Medical Research Methodology, 10: 24.
79. Roquilly A, Gautreau L, Seguin P, Sébille V, Jacqueline C, Caillon J, Potel G, Lejus C, Josien R, Asehnoune K (2010) CpG-ODN and MPLA prevent mortality in a murine model of post-hemorrhage-Staphyloccocus aureus pneumonia. PLoS One, 5(10): e13228.
80. Morvan M, Willem C, Gagne K, Kerdudou N, David G, Sébille V, Folléa G, Bignon JD, Retière C (2009) Phenotypic and functional analyses of KIR3DL1+ and KIR3DS1+ NK cell subsets demonstrate differential regulation by Bw4 molecules and induced KIR3DS1 expression on stimulated NK cells.. J Immunol , 182(11): 6727-6735.
81. Tripodi D, Quéméner S, Renaudin K, Ferron C, Guisle-Marsollier I, Sébille V, Verger C, Géraut C, Gratas-Rabbia-Ré C (2009) Gene expression profiling in sinonasal adenocarcinoma.. BMC Med Genomics , 10(2): 65.
82. Couteau C, El-Boury S, Paparis E, Sébille V, Coiffard L (2009) In vitro UV-A protection factor (PF-UVA) of organic and inorganic sunscreens.. Pharm Dev Technol, 14: 369-372.
83. Thibault R, Goujon N, Le Gallic E, Clairand R, Sébille V, Vibert J, Schneider SM, Darmaun D (2009) Use of 10-point analogue scales to estimate dietary intake: a prospective study in patients nutritionally at-risk.. Clinical Nutrition , 28(2): 134-140.
84. Küry S, Buecher B, Robiou-du-Pont S, Scoul C, Colman H, Le Neel T, Le Houérou C, Faroux R, Ollivry J, Lafraise B, Chupin LD, Sébille V, Bézieau S (2008) Low-penetrance alleles predisposing to sporadic colorectal cancers: a French case-controlled study.. BMC Cancer(8): 326.
85. Guillon S, Clément M, Sébille V, Rivain JG, Chou CF, Ruvoën-Clouet N, Le Pendu J (2008) Inhibition of interaction between SARS-CoV Sprotein an dits cellular receptor by anti-histo blood group antibodies.. Glycobiology, 18(12): 1085-1093.
86. Morvan M, David G, Sébille V, Perrin A, Gagne K, Willem C, Kerdudou N, Denis L, Clemenceau B, Folléa G, Bignon JD, Retière C (2008) Autologous and allogenic HLA KIR ligand environments and activating KIR control KIR NK-cell functions.. European Journal of Immunology, 38(12): 3474-3486.
87. Coron E, Sébille V, Cadiot G, Zerbib F, Ducrotté P, Ducrot F, Pouderoux P, Arts J, Le Rhun M, Piche T, Bruley des Varannes S, Galmiche JP (2008) Consortium de Recherche Indépendant sur le Traitement et l’Exploration du Reflux gastro-oesophagien et de l’Endobrachyoesophage (CRITERE). Clinical trial: radiofrequency energy delivery in PPI-dependent GERD patients.. Aliment Pharmacol Ther., 28(9): 1147-1158.
88. Annane D, Sébille V, Duboc D, Le Heuzay JL, Sadoul N, Bouvier E, Bellissant E (2008) Incidence and prognosis of sustained arrhythmias and conduction abnormalities in critically ill patients.. American journal of respiratory and critical care medicine, 178(1): 20-25.
89. Galmiche JP, Sacher-Huvelin S, Coron E, Cholet F, Ben Soussan E, Sébille V, Filoche B, D'Abrigeon G, Antonietti M, Robaszkiewicz M, Le Rhun M, Ducrotté P (2008) Screening for esophagitis and Barrett’s esophagus with wireless esophageal capsule endoscopy. A multicenter prospective trial in patients with reflux symptoms.. American Journal of Gastroenterology , 103(3): 538-545.
90. Sébille V, Hardouin JB, Mesbah M (2007) Sequential analysis of latent variables using mixed-effect latent variable models: impact of non-informative and informative missing data. Statistics in Medicine, 26(27): 4889-4904.
91. Küry S, Buecher B, Robiou-du-Pont S, Scoul C, Sébille V, Colman H, Le Houérou C, Le Neel T, Bourdon J, Faroux R, Ollivry J, Lafraise B, Chupin LD, Bezieau S. (2007) Combinations of cytochrome P450 gene polymorphisms enhancing the risk for sporadic colorectal cancer related to red meat consumption.. Cancer Epidemiol Biomarkers Prev., 16(7): 1460-1467.
92. Alvarez-Rueda N, Leprieur S, Clemenceau B, Supiot S, Sébille V, Faivre-Chauvet A, Davodeau F, Paris J, Bardet J, Aubry J, Birkle S (2007) Binding Activities and Antitumor Properties of a New Mouse/Human Chimeric Antibody Specific for GD2 Ganglioside Antigen.. Clinical Cancer Research, 13(18): 5613s-5620s.
93. Thibault R, Coron E, Sébille V, Sacher-Huvelin S, Bruley des Varannes S, Gournay J, Galmiche JP (2006) Antireflux surgery for non-erosive and erosive reflux disease in community practice. Alimentary Pharmacology and Therapeutics, 24(4): 621-632.
94. Couteau C, Coiffard L, Sébille V (2006) Influence of excipients on moisturizing effect of urea. Drug Development and Industrial Pharmacy, 32(2): 239-242.
95. Annane D, Sébille V, Bellissant E (2006) Effect of low doses of corticosteroids in sepsic shock patients with or without early acute respiratory distress syndrome. Critical Care Medicine, 34(1): 22-30.
96. Annane D, Sébille V, Bellissant E (2006) Letter to the Editor. Critical Care Medicine: .
97. Sébille V, Bellissant E (2005) Impact of misspecification of the response rate under standard treatment in sequential clinical trials. Fundamental and Clinical Pharmacology: 569-78.
98. Bressollette-Bodin C, Coste-Burel M, Hourmant M, Sébille V, Andre-Garnier E, Imbert-marcille BM (2005) A prospective longitudinal study of BK virus infection in 104 renal transplant recipients. American Journal of Transplantation: 1926-1933.
99. Ripoll N, Nic Dhonnchadha BA, Sébille V, Bourin M, Hascoet M (2005) The four-plates test-retest paradigm to discriminate anxiolytic effects. Psychopharmacology: 73-83.
100. Camus C, Bellissant E, Sébille V, Garo B, Legras A, Renault A, Le Corre P, Donnio PY, Gacouin A, Le Tulzo Y, Thomas R (2005) Prevention of acquired infections in intubated patients with the combination of two decontamination regimens. Critical Care Medicine: 307-314.
101. Bellissant E, Estèbe JP, Sébille V, Ecoffey C (2004) Effect of preoperative oral sustained-release morphine sulfate on postoperative morphine requirements in elective spine surgery. Fundamental and Clinical Pharmacology: 709-714.
102. Siproudhis L, Dinasquet M, Sébille V, Reymann JM, Bellissant E (2004) Differential effects of two types of antidepressants, amitriptyline and fluoxetine, on anorectal motility and visceral perception. Alimentary Pharmacology and Therapeutics: 689-695.
103. Gandon Y, Olivie D, Guyader D, Aube C, Oberti F, Sébille V, Deugnier Y (2004) Non-invasive assessment of hepatic iron stores by MRI. Lancet: 357-362.
104. Sébille V, Auget JL (2004) Evaluating Health-Related Quality of Life: a case-study of differential item functioning analysis in small trials. Communications in Statistics-Theory and Methods, 33(6): 1403-1428.
105. Sébille V, Bellissant E (2003) Sequential methods and group sequential designs for comparative clinical trials. Fundamental and Clinical Pharmacology: 505-16.
106. Siproudhis L, Sébille V, Pigot F, Hémery P, Juguet F, Bellissant E (2003) Lack of efficacy of botulinum toxin in chronic anal fissure. Alimentary Pharmacology and Therapeutics: 515-524.
107. Annane D, Sébille V, Bellissant E (2003) Corticosteroids for patients with septic shock. JAMA: .
108. Annane D, Sébille V, Charpentier C, Bollaert PE, François B, Korach JM, Capellier G, Cohen Y, Barboteu M, Troché G, Chaumet-Riffaut P, Bellissant E (2002) Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA, 288(7): 862-871.
109. Désille M, Malher S, Seguin P, Mallédant Y, Frémond B, Sébille V, Bouix A, Desjardin JF, Joly A, Desbois J, Lebreton Y, Campion JP, Clément B (2002) Reduced encephalopathy in pigs with ischemia-induced acute hepatic failure treated with a bioartificial liver containing alginate-entrapped hepatocytes. Critical Care Medicine, 07: 658-63.

Chapitres d'ouvrage

Articles dans une revue nationale

Publications soumise ou en révision

1. (Soumis) Toscano A, Blanchin M, Bourdon M, Dravet F, Quéreux G, Rosato R, Bonnaud-Antignac A, Sébille V (2018) Longitudinal associations between coping strategies, locus of control and health-related quality of life changes in patients with breast cancer or melanoma.
2. (Soumis) Bourdon M, Blanchin M, Campone M, Quéreux G, Dravet F, Sébille V, Bonnaud-Antignac A (2018) A comparison of post-traumatic growth changes in breast cancer and melanoma.
3. (Soumis) Blanchin M, Guilleux A, Hardouin JB, Sébille V (2017) Searching for an optimal SEM-based method to assess response shift at item level: a simulation study.
4. (Soumis) Blanchin M, Hardouin JB, Le Neel T, Kubis G, Sébille V (2016) CTT and Rasch-based approaches for joint analysis of group and time effects of longitudinal Patient Reported Outcomes: impact of dropout mechanisms..

Participations à des projets

Encadrement/Accompagnement de thèses

Encadrement de stages

Communications scientifiques

Communications orales dans un colloque international (idpers=2)

1. Blanchin M., Guilleux A., Hardouin J.B., Sébille V. Comparison of methods for response shift detection at item level: a simulation study. 25th Annual Conference of the ISOQOL, 25-27 october 2018, Dublin, Ireland, Quality of life research 2018, 27:S126., 2018.
2. Brisson P., Sébille V., Hardouin J.B., Blanchin M. Evaluation of an algorithm to identify response shift and its determinants at the item level using Rasch family models – A simulation study. 25th Annual Conference of the ISOQOL, 25-27 october 2018, Dublin, Ireland, Quality of life research 2018, 27:S31., 2018.
3. Toscano A., Blanchin M., Bonnaud-Antignac A., Bourdon M., Sébille V. Associations between locus of control, coping, and quality of life changes in patients with breast cancer or melanoma. 9th European Conference on Positive Psychology, 27-30 juin 2018, Budapest, 2018.
4. Hardouin J.B., Blanchin M., Vanier A., Sébille V. Several Rasch's and Mokken's models-based algorithms to detect DIF and Response Shift in health study. Rasch Probabilistic Models Conference, 17-19 January 2018, Perth, Australia, 2018.
5. Vanier A., Toscano A., Sébille V., Hardouin J.B. What are all the proposed methods to estimate the minimal clinically important difference of a patient-reported outcomes measure? A systematic review. 24th Annual Conference of the ISOQOL, 18-21 october 2017, Philadelphia, USA, Quality of life research 2017, 26:20., 2017.
6. Blanchin M., Salmon M., Rotonda C., Guillemin F., Sébille V. Identification of response shift at a subgroup level in cancer-related fatigue in breast cancer patients. 24th Annual Conference of the ISOQOL, 18-21 october 2017, Philadelphia, USA, 2017.
7. Blanchin M., Guilleux A., Hardouin J.B., Sébille V. A simulation study for comparison of Item Response Theory and Structural Equation Modeling: Response shift detection at the item level. Workshop “Measuring quality of life: some methodological issues” - Department of psychology, Università degli studi di Torino, 18 novembre 2016, 2016.
8. Hardouin J.B., Vanier A., Blanchin M., Sébille V. Minimal clinically important difference determination for patient reported outcomes in presence of esponse shift: the MIDIPRES project. 23th Annual Conference of the ISOQOL, 19-22 october 2016, Copenhaguen, Denmark, Quality of life research 2016, 25:14-15, 2016.
9. Blanchin M., Hardouin J.B., Sébille V. Response shift detection at item level using Item Response Theory models: influence of using fixed item difficulties. 23rd Annual Conference of the ISOQOL, October 19-22 2016, Copenhagen, Denmark, Quality of life research 2016, 25:61-62, 2016.
10. Blanchin M., Sébille V., Guilleux A., Hardouin J.B. A Guttman errors based method for response shift detection at the individual and item levels. Symposium Response shift effects at the item level. 22nd Annual Conference of the ISOQOL, October 21-24 2015, Vancouver, Canada, Quality of life research 2015, 24: 11, 2015.
11. Guilleux A., Blanchin M., Hardouin J.B., Sébille V. Evaluation of the Oort procedure with simulation study for response shift detection at item level. 22nd Annual Conference of the ISOQOL, October 21-24 2015, Vancouver, Canada, 2015, Quality of life research 2015, 24: 64, 2015.
12. Hardouin J.B., Blanchin M., Sébille V. Use of non parametric item response theory to detect item-level response shift. 22th Annual Conference of the ISOQOL, 21-24 october 2016, Vancouver, Canada, Quality of life research 2015, 24: 11, 2015.
13. Hamel J.F., Sébille V., Roquelaure Y., Hardouin J.B. A mixture partial credit model for identifying latent classes responsible for differential item functionning. 22th Annual Conference of the ISOQOL, 21-24 october 2016, Vancouver, Canada, Quality of life research 2015, 24: 27-28, 2015.
14. Blanchin M., Guilleux A., Hardouin J.B., Sébille V. Assessing change in longitudinal PROMs studies: Using IRT polytomous models to detect and adjust for response shift. 43rd Annual Meeting of the Statistical Society of Canada, June 14-17 2015, Halifax, Canada, 2015.
15. Blanchin M., de Bock E., Kubis G., Le Neel T., Sébille V., Hardouin J.B. Rasch and CTT-based approaches for joint analysis of group and time effects of longitudinal Patient Reported Outcomes: impact of informative and non-informative missing data. 4th International Outcome Measurement Conference, April 21-22 2015, Chicago, USA, 2015.
16. Blanchin M., Guilleux A., Vanier A., Hardouin J.B., Sébille V. Comparison of Item Response Theory and Structural Equation Models for response shift detection at the item level. 21th annual conference of ISOQOL, 15-18 october 2014, Berlin, Germany, Quality of life research 2014, 23: 16-17, 2014.
17. Hamel J.F., Hardouin J.B., Roquelaure Y., Sébille V. Estimating Quality of Life when Differential Item Functioning is Present. 21th annual conference of ISOQOL, 15-18 october 2014, Berlin, Germany, Quality of life research 2014, 23: 17, 2014.
18. Hardouin J.B., Blanchin M., Sébille V. Impact of response-shift on the interpretation of a longitudinal structural equations model: an application on the SATISQOL study. Chronic diseases, adaptation and perceived health: stakes and future, 3-6 juin 2014, Nancy, 2014.
19. Sébille V., Blanchin M., Guilleux A., Vanier A., Guillemin F., Hardouin J.B. Item Response Theory Models for response shift detection with missing data in patient-reported outcomes in longitudinal clinical studies. Sympsium Response Shift and Missing data. 20th annual conference of the ISOQOL, October 9-12, 2013, Miami (USA), 2013, Quality of life research 2013, 22, 2013.
20. Blanchin M., Hardouin J.B., Sébille V. Power and sample size determination for the group comparison of PROs in IRT: impact of a misspecification of the parameters . 20th annual conference of the ISOQOL, October 9-12, 2013, Miami (USA), Quality of life research 2013, 22, 2013.
21. Anthoine E., Moret L., Sébille V., Hardouin J.B. Conducting a Confirmatory Factor Analysis (CFA): how scale characteristics, data characteristics, estimation methods and sample size affect fit indexes?. 20th annual conference of the ISOQOL, October 9-12, 2013, Miami (USA), Quality of life research 2013, 22, 2013.
22. Sébille V., Blanchin M., Hardouin J.B. A simple ratio-based approach for power and sample size determination in Rasch family models . 20th annual conference of the ISOQOL, October 9-12, 2013, Miami (USA), Quality of life research 2013, 22, 2013.
23. Guilleux A., Blanchin M., Hardouin J.B., Sébille V. Interest of Item Response Theory (IRT) to detect and interpret Response-Shift in presence of missing data. Journées scientifiques de l’Université de Nantes, 7 juin 2013, Nantes, France, 2013.
24. de Bock E., Hardouin J.B., Blanchin M., Le Neel T., Kubis G., Dantan E., Sébille V. Analysis of longitudinal Patient-Reported Outcomes with intermittent missing data (informative and non informative): comparison of score and Rasch-based methods. 19th Annual Conference of ISOQOL, 24-27 october 2012, Budapest, Hongrie, Quality of life research 2012, 21: 42-43, 2012.
25. Blanchin M., Hardouin J.B., Guilleux A., Sébille V. Power and sample size determination for the group comparison of PROs in IRT: robustness of a method based on the Cramer-Rao bound. 19th Annual Conference of ISOQOL, 24-27 october 2012, Budapest, Hongrie, Quality of life research 2012, 21: 21, 2012.
26. Sébille V., Vanier A., Hardouin J.B. Towards a comparison of response shift methods. 19th Annual Conference of ISOQOL, 24-27 octobre 2012, Budapest, Hongrie, 2012.
27. Hamel J.F., Hardouin J.B., Le Neel T., Kubis G., Sébille V. Detection of a group effect for patients reported outcomes with Rasch models in the presence of possibly informative missing values. Congrès PROQOL: Patient Reported Outcomes and Quality of Life, 2011, Paris, France, 2011.
28. Lucas J.P., Le Bot B., Glorennec P., Etchevers A., Bretin P., Douay F., Sébille V., Bellanger L., Mandin C. Lead Contamination in French Housing. 21st annual International Society of Exposure Science (ISES) Conference 2011 (24-26 octobre 2011), Baltimore, Etats-Unis., 2011.
29. Sébille V., Blanchin M., Feddag M.L., Amri S., Le Neel T., Kubis G., Guillemin F., Falissard B., Hardouin J.B. Methodological issues regarding the planning and the analyses of PRO related studies. 6th Congress of the Italian Society of Medical Statistics and Clinical Epidemiology (SISMEC), Ancona, Italia, 2011.
30. Hamel J.F., Hardouin J.B., Le Neel T., Kubis G., Sébille V. Rasch models to detect a group effect for Patients Reported Outcomes with possibly informative missing data. International Workshop on "Patient Reported Outcomes and Quality of Life", Annales de l'ISUP (2011), 55(2): 49-52, 2011.
31. Sébille V., Falissard B., Amri S., Feddag M.L., Le Neel T., Kubis G., Guillemin F., Hardouin J.B. Sample size determination for IRT Why should it differ from CTT?. International Workshop on "Patient Reported Outcomes and Quality of Life", Annales de l'ISUP (2011), 55(2): 73-74, 2011.
32. Hardouin J.B., Falissard B., Le Neel T., Kubis G., Guillemin F., Sébille V. Comparison of classical test and item response theories in health. 31st annual conference of the international society of clinical biostatistics (ISCB), August 31-September 2, 2010, 2010.
33. Blanchin M., Hardouin J.B., Le Neel T., Kubis G., Sébille V. Comparison of three methods for the analysis of longitudinal Patient Reported Outcomes. Probabilistic models for measurement in education, psychology, social science and health, June 13-16, 2010, 2010.
34. Sébille V., Amri S., Hardouin J.B. Towards sample size determination for IRT analysis for the comparison of two groups of patients. Probabilistic models for measurement in education, psychology, social science and health, June 13-16, 2010, 2010.
35. Hardouin J.B., Falissard B., Le Neel T., Kubis G., Sébille V. Power with CTT and IRT based approaches for the comparison of two groups of patients. 16th International Meeting of the Psychometric Society, 2009.
36. Blanchin M., Hardouin J.B., Le Neel T., Kubis G., Sébille V. Comparison of three methods for the analysis of longitudinal patient reported outcomes. 16th International Meeting of the Psychometric Society, 2009.
37. Victorri-Vigneau C., Foucher Y., Huet M., Guillou-Landreat M., Sébille V., Jolliet P. Use of an original statistical methodology to identify factors linked with a bad observance in the opiate maintenance treatment follow up. 30th Pharmacovigilance Meeting, 2009.
38. Victorri-Vigneau C., Foucher Y., Huet M., Guillou-Landreat M., Sébille V., Jolliet P. Use of an original statistical methodology to identify factors linked with a bad observance in the opiate maintenance treatment follow up. Fundamental and clinical pharmacology, 2009, 2009.
39. Hardouin J.B., Sébille V. Impact of imputation methods for missing data for the analysis of subjective health outcome measures. International Workshop on Advances in Rasch Modelling - Vannes - France - 4-8 June 2007, 2007.
40. Sébille V., Hardouin J.B. Item Response Theory Models and early stopping of clinical trials with Quality of Life measurements. International Conference on Statistical Latent Variables Models in the Health Sciences, Perugia, Italy, Actes p. 95-96, 2006.
41. Sébille V. Sequential Analysis using Item Response Theory Models. International Conference on Statistical Models for Biomedical and Technical Systems, Limassol, Cyprus, Actes p. 169-170, 2006.
42. Sébille V., Mesbah M. Sequential Analysis of Quality of Life Measurements using Mixed Rasch Models. 26th Annual Conference of the International Society for Clinical Biostatistics (ISCB). Szeged, Hungary, Actes O:34, p. 13, 2005.
43. Sébille V., Mesbah M. Sequential Safety Monitoring of Quality of Life Measurements. European Seminar “Mathematical Methods for Survival Analysis, Reliability and Quality of Life”, Lisieux, 2005.
44. Bellissant E., Estèbe J.P., Sébille V., Ecoffey C. Effet of pre-operative oral sustained-release morphine requirements in elective spine surgery. Annual meeting of the American Society for Clinical Pharmacology and Therapeutics (ASCPT). Orlando, Florida, Clinical Pharmacology and Therapeutics 2005;77(2): P8, 2005.
45. Mesbah M., Challa T., Sébille V. Latent Sequential Analysis of Quality of Life Measurements with the Mixed Partial Credit Model. International Conference on the Future of Statistical Theory and Practice, Hyderabad, India, Actes p. 51, 2004.
46. Sébille V., Auget J.L., Mesbah M. Sequential likelihood ratio test on latent variable. International Conference on: Statistics in Health Sciences. Nantes, France, Actes p.157-158, 2004.
47. De Labriolle A., Leclercq C., Sébille V., Carré F., De Place C., Mabo P., Daubert J.C. PR interval prolongation but not QRS widening is an independent factor of functional intolerance in heart failure patients. Congress of the American College of Cardiology. New Orleans, Journal of the American College of Cardiology 2004 (Suppl), 2004.
48. De Labriolle A., Leclercq C., Sébille V., Carré F., De Place C., Mabo P., Daubert J.C. Influence of electrical and electromechanical cardiac asynchrony on exercise capacity in heart failure patients with chronic left ventricular systolic dysfunction. XXVth Congress of the European Society of Cardiology. Vienne, European Heart Journal (Suppl), 2003.
49. Bellissant E., Sébille V., Annane D. Effect of a seven-day treatment with low doses of hydrocortisone and fludrocortisone on mortality in septic shock patients. 103rd meeting of the American Society for Clinical Pharmacology and Therapeutics (ASCPT). Atlanta, Georgia, P14, 2002.

Poster dans un colloque international (idpers=2)

1. Vanier A., Sébille V., Rouquette A., Hardouin J.B. The quality in reporting of studies determining the Minimal Clinically Important Difference of a patient-reported outcomes: a systematic review and a first proposal of guidelines. 25th Annual Conference of the ISOQOL, 25-27 october 2018, Dublin, Ireland, Quality of life research 2018, 27:S161, 2018.
2. Martin S., Blanchin M., Bourdon M., Bonnaud-Antignac A., Sébille V. Longitudinal study of behavioral and psychological changes following cancer – Measurement and changes in Post-Traumatic Growth over time. 25th Annual Conference of the ISOQOL, 25-27 october 2018, Dublin, Ireland, 2018.
3. Blanchin M., Guilleux A., Hardouin J.B., Sébille V. Comparison of methods for response shift detection at item level: a simulation study . 25th Annual Conference of the ISOQOL, 25-27 october 2018, Dublin, Ireland, 2018.
4. Enjalbert L., Hardouin J.B., Blanchin M., Giral M., Meurette A., Sébille V. Evaluation of quality of life changes in patients on waiting list for kidney transplantation using growth mixture models coupled with latent class analysis. 25th Annual Conference of the ISOQOL, 25-27 october 2018, Dublin, Ireland, Quality of life research 2018, 27:S144-S145, 2018.
5. Woaye Hune P., Vanier A., Pottier P., Sébille V., Hardouin J.B. Practical considerations for the Minimal Clinically Important Difference (MCID) determination for Patient Reported Outcomes Measures (PROMs). 24th Annual Conference of the ISOQOL, 18-21 october 2017, Philadelphia, USA, Quality of life research 2017, 26:69-70, 2017.
6. Vanier A., Malatier L., Blanchin M., Hardouin J.B., Sébille V. What can detect Oort's procedure in terms of size of response shift effect when used in various empirical realistic situations at domain-level? A simulation study. 24th Annual Conference of the ISOQOL, 18-21 october 2017, Philadelphia, USA, Quality of life research 2017, 26:71, 2017.
7. Enjalbert L., Hardouin J.B., Giral M., Meurette A., Sébille V. . Comparison of quality of life in pre-emptive and dialyzed patients on waiting list for kidney transplantation. Exploring differential item functioning using Rasch Measurement Theory Models. 24th Annual Conference of the ISOQOL, 18-21 october 2017, Philadelphia, USA, Quality of life research 2017, 26:128-129, 2017.
8. Sébille V., Hammas K., Bonnaud-Antignac A., Blanchin M. Identification of response shift at the item level on quality of life changes in breast cancer and melanoma patients using Rasch family models – what is the impact of covariates?. 24th Annual Conference of the ISOQOL, 18-21 october 2017, Philadelphia, USA, 2017.
9. Toscano A., Blanchin M., Bonnaud-Antignac A., Sébille V. Locus of control and coping as predictors of the change of Health-Related Quality of Life over time in breast cancer and melanoma patients. 24thAnnual Conference of the ISOQOL, 18-21 october 2017, Philadelphia, USA, 2017.
10. Sébille V., Hardouin J.B., Tessier P., Bonnaud-Antignac A., Giral M., Meurette A. A. Comparison of quality of life of pre-emptive or dialyzed patients on waiting list for kidney transplantation. prospective, observational, multicenter controlled study. Is differential item functioning occurring and is it an issue for the comparison?. 23h Annual Conference of the ISOQOL, 19-22 october 2016, Copenhaguen, Denmark, Quality of life research 2016, 25: 145, 2016.
11. Blanchin M., Guilleux A., Vanier A., Hardouin J.B., Sébille V. Response shift detection at the item level – A comparison of Item Response Theory and Structural Equation Models-based methods. 22nd Annual Conference of the ISOQOL, 21-24 october 2015, Vancouver, Canada, 2015, Quality of life research 2015, 24: 148, 2015.
12. Sébille V., Hardouin J.B., Bonnaud-Antignac A., Tessier P., Giral M., Foucher Y., Meurette A. A. Response shift in patients receiving a pre-emptive kidney transplant compared to similar recipients having experienced a short dialysis period: study protocol for a prospective, observational, multicenter controlled study. 22th Annual Conference of the ISOQOL, 21-24 october 2016, Vancouver, Canada, Quality of life research 2015, 24: 63, 2015.
13. Vanier A., Sébille V., Blanchin M., Guilleux A., Hardouin J.B. Power and Type-I-Error of global assessment of response shift occurrence using Likelihood-Ratio Test or information criteria in Oort’s procedure: a simulation study. 21th annual conference of ISOQOL, 15-18 october 2014, Berlin, Germany, Quality of life research 2014, 23: 99-100, 2014.
14. Vanier A., Leplège A., Hardouin J.B., Sébille V., Falissard B. Semantic primes: a possible way to avoid Response Shift?. 21th annual conference of ISOQOL, 15-18 october 2014, Berlin, Germany, Quality of life research 2014, 23: 165, 2014.
15. Guilleux A., Blanchin M., Vanier A., Hardouin J.B., Sébille V. Searching for an optimal SEM-based method for response shift detection in longitudinal patient-reported outcomes studies – A simulation study. 21th annual conference of ISOQOL, 15-18 october 2014, Berlin, Germany, Quality of life research 2014, 23: 184, 2014.
16. Anthoine E., Moret L., Sébille V., Hardouin J.B. Sample size determination when conducting a Confirmatory Factor Analysis (CFA): how sample size, scale characteristics, data characteristics and estimation methods affect fit indexes?. 21th annual conference of ISOQOL, 15-18 october 2014, Berlin, Germany, Quality of life research 2014, 23: 165, 2014.
17. Perrot B., Le Neel T., Hamel J.F., Blanchin M., Sébille V., Hardouin J.B. PRO-Online: a free online software to analyse patient-reported outcomes using various paradigms of data analysis. 21h Annual Conference of the ISOQOL, 15-18 october 2014, Berlin, Germany, Quality of life research 2014, 23: 118-119, 2014.
18. Hardouin J.B., Blanchin M., Sébille V. A Guttman’s errors based method for Response-Shift detection at the individual level: algorithm and comparison with the Ahmed’s procedure. 21th annual conference of ISOQOL, 15-18 october 2014, Berlin, Germany, Quality of life research 2014, 23: 81, 2014.
19. Feuillet F., Victorri-Vigneau C., Hardouin J.B., Sébille V. A validation algorithm for detecting dose increase from longitudinal data of psychotropic drug users using Monte Carlo simulation. International Society for Clinical Biostatistics, 35th Annual Conference, 24-28 August 2014, Vienna, Austria, 2014.
20. Hardouin J.B., Blanchin M., Hamel J.F., Le Neel T., Sébille V. Online analyses of PRO using CTT and IRT methods for the validation or the analysis of scale or for the planning of studies. 20th annual conference of the ISOQOL, October 9-12, 2013, Miami (USA), Quality of life research 2013, 22, 2013.
21. Feuillet F., Victorri-Vigneau C., Hardouin J.B., Pivette J., Chaslerie A., Sébille V., Jolliet P. Latent class analysis: a new approach to characterize psychotropic drug consumption. 29th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, August 25-28, 2013,Montreal, Canada, Pharmacoemidemiology & Drug safety 2013, 22(S1):504, 2013.
22. Péron E., Hardouin J.B., Sébille V., Chaslerie A., Pivette J., Jolliet P., Victorri-Vigneau C. Application of a Cox model accros a refunds database: A new approach to compare Selective Serotonin Reuptake Inhibitors (SSRI). 29th international conference on Pharmacoepidemiology and Therapeutic Risk Management, August 25-28, 2013, Montréal, Canada, Pharmacoemidemiology & Drug safety 2013, 22(S1):121, 2013.
23. Collin C., Feuillet F., Victorri-Vigneau C., Courné M.A., Hardouin J.B., Sébille V. Changes in daily dose over time from longitudinal data of tianeptine users: convergence of two different approaches . International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE), Montreal, 25-28 août 2013, Pharmacoemidemiology & Drug safety 2013, 22(S1):265, 2013.
24. Rouquette A., Blanchin M., Sébille V., Guillemin F., Côté S.M., Falissard B., Hardouin J.B. Determination of the Minimal Clinically Important Difference (MCID) using Item Response Theory (IRT) models: an attempt to solve the issue of the association with baseline score. International workshop on "Response-Shift and subjective measures in health science", 7 juin 2013, Nantes, 2013.
25. Hardouin J.B., Amri S., Feddag M.L., Sébille V. Towards power and sample size calculations for the comparison of two groups of patients with item response theory models. 19th Annual Conference of ISOQOL, 24-27 october 2012, Budapest, Hongrie, Quality of life research 2012, 21: 277, 2012.
26. Anthoine E., Hardouin J.B., Moret L., Sébille V. Practices in PRO psychometric validation studies: a systematic literature review. 19th Annual Conference of ISOQOL, 24-27 october 2012, Budapest, Hongrie, Quality of life research 2012, 21: 70, 2012.
27. de Bock E., Hardouin J.B., Blanchin M., Le Neel T., Kubis G., Sébille V. Analysis of longitudinal Patient-Reported Outcomes with intermittent missing data (informative and non informative): comparison of score or Rasch-based methods. International Workshop on "Patient Reported Outcomes and Quality of Life", Annales de l'ISUP (2011), 55(2): 43-46, 2011.
28. Hamel J.F., Hardouin J.B., Le Neel T., Kubis G., Sébille V. Rasch models to detect a group effect for Patients Reported Outcomes. 31st annual conference of the international society of clinical biostatistics (ISCB), August 31-September 2, 2010, 2010.
29. Blanchin M., Hardouin J.B., Le Neel T., Kubis G., Sébille V. Analysis of longitudinal Patient Reported Outcomes with missing data. 31st annual conference of the international society of clinical biostatistics (ISCB), August 31-September 2, 2010, 2010.
30. Hamel J.F., Hardouin J.B., Le Neel T., Kubis G., Sébille V. Rasch models to detect a group effect for Patients Reported Outcomes. International Society for Clinical Biostatistics congress, 2010, France, 2010.
31. Blanchin M., Hardouin J.B., Le Neel T., Kubis G., Sébille V. Comparison of three methods for the analysis of longitudinal Patient Reported Outcomes. 6th International Meeting on Recent Advances & Trends in Statistics Applied to Clinical Trials, 2009.
32. Hardouin J.B., Falissard B., Le Neel T., Kubis G., Sébille V. Power with CTT and IRT based approaches for the comparison of two groups of patients. . 6th International Meeting Recent Advances & Trends in Statistics Applied to Clinical Trials, 2009.
33. Blanchin M., Hardouin J.B., Le Neel T., Bonnaud-Antignac A., Sébille V. Comparison of three methods for the analysis of longitudinal Patient Reported Outcomes. Journées Scientifiques de l’Université de Nantes, juin 2008, Nantes, 2008.

Communications orales dans un colloque national (idpers=2)

1. Bourdon M., Blanchin M., Tessier P., Campone M., Quéreux G., Dravet F., Sébille V., Bonnaud-Antignac A. Etude Longitudinale des Changements psychologiques et Comportementaux suite à un CAncer du sein ou à un mélanome (ELCCA) : évolution de la fatigue dans les deux années suivant le diagnostic. Fatigue liée au cancer: regards croisés, 25 octobre 2018, Le Mans, 2018.
2. Toscano A., Blanchin M., Bonnaud-Antignac A., Bourdon M., Sébille V. Quels liens entre les stratégies de coping, le contrôle perçu et la qualité de vie au cours du temps? Étude auprès de patients atteints d’un cancer du sein ou d’un mélanome. 10e congrès de l'Association Francophone de Psychologie de la Santé (AFPSA), 13-15 juin 2018, Metz, 2018.
3. Blanchin M., Hammas K., Hardouin J.B., Sébille V. Comparaison de la qualité de vie des patients atteints de cancer du sein ou de mélanome en prenant en compte l’adaptation des patients à leur maladie (« response shift »). 12e Conférence francophone d’Épidémiologie clinique 25e Journée des statisticiens des Centres de lutte contre le cancer, 30 mai-1er juin 2018, Nice, France, Revues d'Epidémiologie et de Santé Publique 2018, 66(3): S128-S129, 2018.
4. Blanchin M., Guilleux A., Hardouin J.B., Sébille V. Comparaison de deux méthodes basées sur la théorie de réponse aux items et les modèles à équations structurelles pour la détection du response shift. 10e conférence francophone d'épidémiologie clinique (EPICLIN 2016) et 23e journées des statisticiens des centres de lutte contre le cancer, 25-27 mai 2016, Strasbourg, 2016.
5. Hamel J.F., Hardouin J.B., Roquelaure Y., Sébille V. Evaluation de la qualité de vie en présence de DIF chez des patients souffrant de lombalgie chronique. Chronic diseases, adaptation and perceived health: stakes and future - Young Researchers Days, 3-6 juin 2014, Nancy, 2014.
6. de Bock E., Hardouin J.B., Blanchin M., Le Neel T., Kubis G., Sébille V. Comparaison de la CTT et de l'IRT pour analyser des PRO longitudinaux comportant des données manquantes intermittentes. Chronic diseases, adaptation and perceived health: stakes and future - Young Researchers Days, 3-6 juin 2014, Nancy, 2014.
7. Vanier A., Leplège A., Hardouin J.B., Sébille V., Falissard B. Semantic primes, une possibilité pour éviter le Response Shift ?. Chronic diseases, adaptation and perceived health: stakes and future - Young Researchers Days, 3-6 juin 2014, Nancy, 2014.
8. Feuillet F., Victorri-Vigneau C., Hardouin J.B., Sébille V. Validation d’un algorithme de détection de l’augmentation de la dose pour la consommation de médicaments psychotropes. EPICLIN, Bordeaux, 14-16 mai 2014, 2014.
9. Sébille V., Blanchin M., Guilleux A., Rouquette A., Feddag M.L., Le Neel T., Kubis G., Falissard B., Guillemin F., Hardouin J.B. How could we design studies on PRO data? The PLANIPRO project. Evaluation et analyse de la qualité de vie : nouveaux développements méthodologiques, 3-4 avril 2014, Montpellier, 2014.
10. Blanchin M., Guilleux A., Vanier A., Hardouin J.B., Sébille V. Development of a RespOnse Shift ALgorithm in Item response theory (ROSALI) for response shift detection in longitudinal patient-reported outcomes studies. Evaluation et analyse de la qualité de vie : nouveaux développements méthodologiques, 3-4 avril 2014, Montpellier, 2014.
11. Moret L., Hardouin J.B., Sébille V. Impact de l'absentéisme des professionnels soignants sur la satisfaction des patients hospitalisés : une étude exploratoire au CHU de Nantes . Santé Publique et Prévention - congrès de l'ADELF-SFSP, 17-19 octobre 2013, Bordeaux, France, 2013.
12. Guilleux A., Blanchin M., Vanier A., Hardouin J.B., Sébille V. Comparison of Structural Equations Modeling (SEM) and Item Response Theory (IRT) models to detect and take into account Response-Shift. Quels apports des mathématiques à la mesure de la qualité de vie en oncologie, 11-12 septembre 2012, Marseille, France, 2013.
13. Hardouin J.B., de Bock E., Blanchin M., Hamel J.F., Sébille V. Interest of Item Response Theory (IRT) models for handling missing data in cross-sectional or longitudinal designs . Quels apports des mathématiques à la mesure de la qualité de vie en oncologie, 11-12 septembre 2012, Marseille, France, 2013.
14. Rouquette A., Blanchin M., Sébille V., Guillemin F., Côté S.M., Falissard B., Hardouin J.B. Utilisation des modèles issus de la Théorie de Réponse à l’Item (IRT) pour la détermination de la Différence Minimale Cliniquement Pertinente d’un questionnaire. EPICLIN 7 - 7ème Conférence Francophone d'Épidémiologie Clinique, 16 & 17 mai 2013 - Paris, 2013.
15. de Bock E., Hardouin J.B., Blanchin M., Le Neel T., Kubis G., Dantan E., Sébille V. Analyse de PRO recueillis de façon longitudinale et comportant des données manquantes intermittentes potentiellement informatives : comparaison de modèles issus de la théorie classique des tests et de la théorie de réponse aux items. GDR statistique et santé, 20 et 21 septembre 2012, Rennes, France, 2012.
16. Feddag M.L., Hardouin J.B., Blanchin M., Sébille V. Analyse de la puissance d'une étude transversale à deux groupes pour le modèle crédit partiel. 44e journées de la société française de statistique (SFdS), Bruxelles, 21-25 mai 2012, 2012.
17. Cozian G., Sébille V. Validation pharmacologique, clinique et statistique à partir des données du réseau national des CEIPs d'un nouvel outil d'évaluation en pharmacodépendance. Recherche en Pharmaco-épidémiologie, Nantes, 2009.
18. Blanchin M., Hardouin J.B., Le Neel T., Kubis G., Sébille V. Comparaison de trois méthodes d’analyse des variables latentes longitudinales,. 41èmes Journées de Statistique - Bordeaux, 2009.
19. Hardouin J.B., Sébille V. Comparaison de méthodes d'imputation de données manquantes pour l'analyse de mesures subjectives en santé . Biostatistique et mesures subjectives en santé, Nantes, 2008, 2008.
20. Sébille V., Hardouin J.B., Bonnaud-Antignac A. Les bio-statistiques et la qualité de vie en cancérologie. Etude longitudinale de la qualité de vie et des stratégies de coping des patientes atteintes de cancer du sein et de leur entourage. 3ème Symposium Sciences Humaines et Sociales – Cancéropôle Grand Ouest, 25 octobre 2007, 2007.
21. Hardouin J.B., Sébille V. Impact des méthodes d'imputation de données manquantes pour l'analyse de mesures subjectives en santé. 39e journées de la statistique, Angers, 2007, 2007.
22. Thibault R., Goujon N., Clairand R., Sébille V., Darmaun D. Evaluation prospective d'une échelle verbale de quantification des ingesta: une étude pilote de faisabilité. 24ème congrès annuel de la Société Francophone de Nutrition Entérale et Parentérale (SFNEP). Bordeaux, Nutr Clin Métab 2005; 19 (Suppl 1): S75, 2005.
23. Bellissant E., Sébille V., Annane D. For the GER-INF 05 study group, Effect of a seven-day treatment with low doses of hydrocortisone and fludrocortisone on mortality in septic shock patients. 6ème Congrès Annuel de la Société Française de Pharmacologie (SFP). 23ème Journées de Pharmacovigilance. Joint Meeting with Pharmacological Societies of Brazil and Portugal. Rennes, A-36, 2002.
24. Reymann J.M., Dinasquet M., Sébille V., Siproudhis L., Bellissant E. Effect of antidepressants on visceral perception and anorectal motility. 6ème Congrès Annuel de la Société Française de Pharmacologie (SFP). 23ème Journées de Pharmacovigilance. Joint Meeting with Pharmacological Societies of Brazil and Portugal. Rennes, Fundamental and Clinical Pharmacology 2002;16:426 (A-346), 2002.
25. Sébille V., Bellissant E., Estèbe J.P., Ecoffey C. Effect of pre-operative oral sustained-release morphine sulphate on post-operative morphine requirements in scheduled spine surgery. 6ème Congrès Annuel de la Société Française de Pharmacologie (SFP). 23ème Journées de Pharmacovigilance. Joint Meeting with Pharmacological Societies of Brazil and Portugal. Rennes, Fundamental and Clinical Pharmacology 2002;16:430 (A-367), 2002.

Poster dans un colloque national (idpers=2)

1. Enjalbert L., Hardouin J.B., Blanchin M., Giral M., Meurette A., Sébille V. Évaluation de l’évolution de la qualité de vie des patients préemptifs et dialysés sur liste d’attente d’une transplantation rénale : étude de l’invariance de la mesure. 12e Conférence francophone d’Épidémiologie clinique 25e Journée des statisticiens des Centres de lutte contre le cancer, 30 mai-1er juin 2018, Nice, France, Revues d'Epidémiologie et de Santé Publique 2018, 66(3): S150, 2018.
2. Blanchin M., Hardouin J.B., Tessier P., Bonnaud-Antignac A., Sébille V. Power and sample size using Rasch model: A longitudinal study of psychosocial changes after cancer. Chronic diseases, adaptation and perceived health: stakes and future - Young Researchers Days, 3-6 juin 2014, Nancy, 2014.
3. Guilleux A., Blanchin M., Vanier A., Hardouin J.B., Sébille V. Searching for an optimal SEM-based method for response shift detection in longitudinal patient-reported outcomes studies – A simulation study. Chronic diseases, adaptation and perceived health: stakes and future - Young Researchers Days, 3-6 juin 2014, Nancy, 2014.
4. Perrot B., Le Neel T., Hamel J.F., Blanchin M., Sébille V., Hardouin J.B. Online analyses of PRO using CTT and IRT methods for the validation or the analysis of scales or for the planning of studies. Chronic diseases, adaptation and perceived health: stakes and future - Young Researchers Days, 3-6 juin 2014, Nancy, 2014.
5. Péron E., Hardouin J.B., Feuillet F., Sébille V., Wainstein L., Jolliet P., Victorri-Vigneau C. Application d'un modèle de Cox : Une nouvelle approche pour comparer les inhibiteurs sélectifs de la recapture de la Sérotonine (ISRS). 8e congrès de physiologie, de pharmacologie et de thérapeutique, 22-24 avril 2013, Angers, France, 2013.
6. Péron E., Hardouin J.B., Feuillet F., Sébille V., Wainstein L., Jolliet P., Victorri-Vigneau C. Selective Serotonin Reuptake Inhibitors effectiveness assessment in real life conditions. 8ème Congrès de Physiologie de Pharmacologie et de thérapeutique, Angers, 22-24 avril 2013, 2013.
7. Lagadec M., Challet G., Caillon J., Vénisse J.L., Sébille V., Grall-Bronnec M. Etude des styles de défense intrapsychiques d'une cohorte de joueurs problématiques débutant des soins. 5èmes journées de l’Albatros, 9, 10 et 11 juin 2011, Paris, 2011.
8. Ouadi A., Bonnaud-Antignac A., Biacabe S., Hardouin J.B., Dréno L., Jean A., Nazih F., Sébille V., Tessier P., Burban C., Sarrazin A., Laboux O., Pineau A. et Rogez JM. Etude du vécu des étudiants en Première Année Commune aux Etudes de Santé (PAES) de l’Université de Nantes Approche qualitative. Journées Scientifiques de l’Université de Nantes. Les Sciences Humaines au chevet de la médecine, 06 juin 2011, Nantes, France, 2011.
9. Rousselet M., Victorri-Vigneau C., Gérardin M., Sébille V., Hardouin J.B., Planche L., Jolliet P. Score d’évaluation de la pharmacodépendance à une substance : processus de validation. 6èmes Congrès de Physiologie, pharmacologie et thérapeutique, 22-24 mars 2011, Grenoble, 2011.
10. Wainstein L., Victorri-Vigneau C., Sébille V., Feuillet F., Pivette J., Chaslerie A., Jolliet P. Evaluation de la reproductibilité de l’analyse en classes latentes dans la caractérisation de profils de consommateurs de bromazépam à partir des bases de données de l’Assurance Maladie. 6ème Congres Annuel de la Société Française de Pharmacologie et de Thérapeutique, 22-24 mars 2011, Grenoble, 2011.
11. Guillou-Landreat M., Louvigne C., Victorri-Vigneau C., Sébille V., Vénisse J.L., Jolliet P. Le dosage urinaire : un outil indispensable au suivi des traitements de substitution aux opiacés.. 9ème congrès de l’Encéphale, Palais des congrès, Paris, 19-21 janvier 2011., 2011.
12. Roquilly A., Mahé P.J., Sébille V., Feuillet F., Rimbert M., Asehnoune K. Facteur de risques des défaillances d'organes après polytraumatisme. 53 ème congrès de la SFAR (R004), Paris, 2011, 2011.
13. Rousselet M., Victorri-Vigneau C., Gérardin M., Sébille V., Hardouin J.B., Planche L., Guerlais M., Jolliet P. Score d’évaluation de la pharmacodépendance à une substance : processus de validation. 6èmes ateliers de la pharmacodépendance et addictovigilance, 25-26 octobre 2010, Biarritz, 2010.
14. Victorri-Vigneau C., Wainstein L., Sébille V., Jolliet P. Evaluation pharmacoépidémiologique de l’utilisation du zolpidem et résultats de la surveillance des CEIP : une même évidence du potentiel de dépendance. 14ème Congres Annuel de la Société Française de Pharmacologie et de Thérapeutique, 23-25 mars 2010, Bordeaux, 2010.
15. Feuillet F., Hardouin J.B., Wainstein L., Victorri-Vigneau C., Jolliet P., Sébille V. . Caractérisation pharmaco-épidémiologique de patients consommateurs de médicaments psychotropes : apport des modèles à classes latentes. Journées scientifiques de l'Université de Nantes : recherche en pharmaco-épidémiologie, 8 juin 2009, Nantes, 2009.
16. Wainstein L., Sébille V., Victorri-Vigneau C., Feuillet F., Pivette J., Jolliet P. Application d'un modèle d'analyse en classes latentes aux bases de données d'une Caisse Régionale de l'Assurance Maladie: exemple du bromazépam. Journées scientifiques de l’Université de Nantes, 8 juin 2009, Nantes, 2009.
17. Wainstein L., Sébille V., Victorri-Vigneau C., Feuillet F., Jolliet P. Caractérisation de groupes de consommateurs de bromazépam: Application d'un modèle d'analyse en classes latentes aux bases de données d'une Caisse Régionale de l'Assurance Maladie. 4ème Séminaire scientifique de Pharmaco-épidémiologie ADELF-AFCROS, 14-15 mai 2009, Paris, 2009.
18. Blanchin M., Hardouin J.B., Le Neel T., Kubis G., Sébille V. Comparison of three methods for the analysis of longitudinal Patient Reported Outcomes. Epidémiologie et Biomètrie 2008, 2008.
19. Léger J., Hardouin J.B., Bonnaud-Antignac A., Sébille V. Analyse longitudinale de données de qualité de vie de patientes atteintes de cancer du sein : influence du coping et des caractéristiques des patientes. Biostatistique et mesures subjectives en santé, Nantes, 2008, 2008.
20. Blanchin M., Hardouin J.B., Le Neel T., Kubis G., Bonnaud-Antignac A., Sébille V. Comparison of three methods for the analysis of longitudinal Patient Reported Outcomes. Biostatistique et mesures subjectives en santé, Nantes, 2008, 2008.
21. Huet M., Foucher Y., Guillou-Landreat M., Victorri-Vigneau C., Jolliet P., Sébille V. Chaines de Markov non homogènes d'ordre 1 à temps discrets appliqués à l'étude de l'observance de patients toxicomanes substitués au Subutex. Biostatistique et mesures subjectives en santé, Nantes, 2008, 2008.
22. Pottier P., Hardouin J.B., Planchon B., Sébille V., Barrier J.H. Validation d'un nouvel outil d'évaluation individuelle des stratégies de résolution de problème basé sur la rédaction de cartes conceptuelles chez les étudiants en 5ème année de Médecine. Biostatistique et mesures subjectives en santé, Nantes, 2008, 2008.
23. Bellanger L., Victorri-Vigneau C., Jolliet P., Sébille V. Determination of an oversonsumption's threshold for the evaluation of abuse and dependence potential of drug. Biostatistique et mesures subjectives en santé, Nantes, 2008, 2008.
24. Hardouin J.B., Le Neel T., Kubis G., Sébille V. Comparaison de mesures issues de Patients Reported Outcomes entre deux groupes de patients : identification de facteurs influant sur la puissance. Biostatistique et mesures subjectives en santé, Nantes, 2008, 2008.
25. Leger J., Hardouin J.B., Bonnaud-Antignac A., Sébille V. Analyse longitudinale de la qualité de vie de patientes atteintes de cancer du sein : Influence du coping et des caractéristiques des patients et de leurs accompagnants. Journées Scientifiques de l’Université de Nantes, juin 2008, Nantes, 2008.

Communications orales dans un colloque local (idpers=2)

1. Hardouin J.B., Vanier A., Blanchin M., Leroy M., Rouquette A., Sébille V., Toscano A., Woaye Hune P. Comparaison des méthodes de détermination de la différences minimale cliniquement pertinente (MCID) sur des scores issus de données rapportées par les patients (PRO) à l'aide d'études de simulation : le projet MIDIPRES. Séminaire de l'UMR CNRS 5558 "Biométrie et Biologie Evolutive", 2018.
2. Vanier A., Leplège A., Hardouin J.B., Sébille V., Falissard B. Some conceptual issues concerning Response Shift in HRQL measurement. International Workshop “Response Shift and subjective measures in health sciences”, 7 Juin, Journées Scientifiques de l'Université de Nantes, Nantes, 2013.
3. Sébille V., Hardouin J.B., Bonnaud-Antignac A. Biostatistique & Qualité de Vie en Cancérologie : Étude longitudinale de la qualité de vie et des stratégies de coping des patientes atteintes de cancer du sein et de leur entourage. "Qualité de vie et cancer : pourquoi ? Comment ?" organisé par le Cancéropole Grand ouest, Nantes, 22 octobre 2007, 2007.